CLONICAINE
LIVE

Serial Number

98542054

Owner

CAD Therapeutics, Inc.

Attorney

Joseph R. Falcon

Filing Date

May 9, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CLONICAINE Trademark

Serial Number: 98542054

CLONICAINE is a trademark filed by CAD Therapeutics, Inc. on May 9, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

CAD Therapeutics, Inc. (2 trademarks)

New York, NY 10013

Entity Type: 03

Trademark Details

Filing Date

May 9, 2024

Registration Date

Not Registered

Published for Opposition

April 29, 2025

Goods & Services

Pharmaceutical preparations for the treatment and prevention of hot flashes; Pharmaceutical preparations for the treatment of post traumatic stress disorder

Filing History

TEAS POST PUBLICATION AMENDMENT RECEIVED
Jun 17, 2026 EPPA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 1, 2026 EXRA
SOU EXTENSION 2 GRANTED
Jun 1, 2026 EX2G
SOU EXTENSION 2 FILED
Jun 1, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 1, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 4, 2025 EXRA
SOU EXTENSION 1 GRANTED
Dec 3, 2025 EX1G
SOU EXTENSION 1 FILED
Dec 3, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 3, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 24, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 29, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 29, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 23, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 27, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 27, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 27, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 12, 2025 GNFN
FINAL REFUSAL E-MAILED
Feb 12, 2025 GNFR
FINAL REFUSAL WRITTEN
Feb 12, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 8, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 8, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 27, 2024 GNRN
NON-FINAL ACTION E-MAILED
Nov 27, 2024 GNRT
NON-FINAL ACTION WRITTEN
Nov 27, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 22, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 7, 2024 NWOS
NEW APPLICATION ENTERED
May 9, 2024 NWAP